NCT06775834View on ClinicalTrials.gov

Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

February 11, 2025

Primary Completion Date

July 23, 2025

Study Completion Date

July 23, 2025

Conditions

Hypertrophic Cardiomyopathy

Interventions

DRUG

HRS-1893

HRS-1893 tablets.

Trial Locations (1)

610072

Sichuan Provincial People's Hospital, Chengdu

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY